Werner Stock Hits New 52-Week High (WERN)

NEW YORK ( TheStreet) -- Werner (Nasdaq: WERN) hit a new 52-week high Thursday as it traded at $26.15 compared with its previous 52-Week high of $25.98. Werner is changing hands at $26.04 with 19,724 shares traded as of 9:32 a.m. ET. Average volume has been 829,700 shares over the past 30 days.

Werner has a market cap of $1.8 billion and is part of the services sector and transportation industry. Shares are up 13.1% year to date as of the close of trading on Wednesday.

Werner Enterprises, Inc., a transportation and logistics company, engages in hauling the truckload shipments of general commodities in interstate and intrastate commerce in the United States, Canada, Mexico, and internationally. The company has a P/E ratio of 22.9, equal to the average transportation industry P/E ratio and above the S&P 500 P/E ratio of 15.9.

TheStreet Ratings rates Werner as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Werner Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant